$58.7 Million is the total value of Versant Venture Management, LLC's 8 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | $32,581,000 | +7.5% | 498,558 | 0.0% | 55.55% | +19.6% | |
| GRTS | Gritstone Oncology, Inc. | $9,152,000 | +6.2% | 3,561,150 | 0.0% | 15.60% | +18.1% | |
| PASG | Passage Bio, Inc. | $6,200,000 | -47.0% | 4,959,769 | 0.0% | 10.57% | -41.1% | |
| ADVM | Adverum Biotechnologies, Inc. | $4,815,000 | -20.8% | 5,068,233 | 0.0% | 8.21% | -12.0% | |
| ALGS | Aligos Therapeutics, Inc. | $2,552,000 | -9.1% | 2,320,381 | 0.0% | 4.35% | +1.1% | |
| CBAY | CymaBay Therapeutics, Inc. | $1,903,000 | +18.6% | 543,753 | 0.0% | 3.24% | +31.9% | |
| Minerva Surgical Inc. | $1,331,000 | -66.2% | 1,673,700 | 0.0% | 2.27% | -62.4% | ||
| CLVS | Clovis Oncology, Inc. | $121,000 | -33.9% | 101,855 | 0.0% | 0.21% | -26.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CymaBay Therapeutics, Inc. | 35 | Q2 2023 | 10.2% |
| Clovis Oncology, Inc. | 32 | Q3 2022 | 53.2% |
| CRISPR Therapeutics AG | 23 | Q3 2023 | 77.2% |
| Ocular Therapeutix, Inc. | 22 | Q4 2020 | 18.0% |
| Gritstone Oncology, Inc. | 18 | Q3 2023 | 25.4% |
| Achaogen, Inc. | 18 | Q1 2019 | 23.5% |
| Adverum Biotechnologies, Inc. | 15 | Q3 2023 | 21.0% |
| Second Sight Medical Products, Inc. | 15 | Q3 2020 | 9.0% |
| Audentes Therapeutics, Inc. | 13 | Q3 2019 | 39.6% |
| Aligos Therapeutics, Inc. | 12 | Q3 2023 | 15.7% |
View Versant Venture Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-08 |
| 13F-HR | 2023-11-03 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-11 |
| 144 | 2023-04-20 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-02-11 |
View Versant Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.